Prostaglandin H2 [prostaglandin H2]
- Terms
-
PGH2
-
PGH(2)
PGH2
A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.
- Annotation
- /analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinent
- DUI
- D044262 MeSH Browser
- CUI
- M0086362
- CAS
- Prosta-5,13-dien-1-oic acid, 9,11-epidioxy-15-hydroxy-, (5Z,9alpha,11alpha,13E,15S)-
- Previous indexing
- Prostaglandin Endoperoxides, Synthetic (1986-1992); Prostaglandins H (1993-2003)
- History note
- 2004; use PROSTAGLANDIN H2 (NM) 1980-2003
- Public note
- 2004; PROSTAGLANDIN H2 was indexed under PROSTAGLANDINS H 1993-2003 & PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
9,11-etheno-16-(4-fluorophenoxyprostaglandin) H2 Chemical MeSH Browser
prostaglandin H2 9-cyclic ether Chemical MeSH Browser
prostaglandin H2 methyl ester Chemical MeSH Browser